Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q3 2014

IBB Guru Trades in Q3 2014

George Soros 150,000 sh (unchged)
» More
Q4 2014

IBB Guru Trades in Q4 2014

John Keeley 905 sh (New)
» More
Q1 2015

IBB Guru Trades in Q1 2015

John Keeley 905 sh (unchged)
» More
Q2 2015

IBB Guru Trades in Q2 2015

George Soros 2,400 sh (New)
John Keeley 905 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with IBB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: »
Compare:0 » details
» More Articles for IBB

Headlines

Articles On GuruFocus.com
Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. (NasdaqCM: IMNP); $6.00 Price Targe Jul 23 2015 
Shen Jun 24 2015 
Shen Jun 24 2015 
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 

More From Other Websites
Regeneron: A Downgrade With a Positive Bias? Aug 31 2015
Stock Market Video Analysis 8/28/15 Aug 28 2015
Why This Small Biotech May Be Ready to Explode Aug 28 2015
Amgen v. Regeneron: Everyone Wins? Aug 28 2015
Cramer: China & biotech - it's complicated Aug 27 2015
Does China have its act together? Aug 27 2015
Did The Fed Intentionally Spark A Commodity Sell-off? Aug 27 2015
Acadia Pharmaceuticals Fell 19% after Reporting 2Q15 Earnings Aug 27 2015
How Has Aquinox Performed Compared to Peers? Aug 27 2015
By the numbers: Markets roar back from declines Aug 26 2015
Dow, S&P close lower in biggest reversal since Oct. 08 Aug 25 2015
Some Pharma Stocks Trade below All Moving Averages in Early August Aug 25 2015
Pharmaceutical Stocks Affect the iShares NASDAQ Biotechnology ETF Aug 25 2015
Shire Falls but Mylan’s Rise Boosts Large-Cap IBB Pharma Subgroup Aug 25 2015
IBB ETF Pounded by Biotech and Pharma Subgroups in Early August Aug 25 2015
AMAG is a Hidden Biotech Gem That is Exploding Aug 25 2015
What Are IBB and XBI’s Valuations? Aug 25 2015
An Inside Look at Biotech Investor Pros Dealing With Market Meltdown Aug 25 2015
Aquinox Improves Net Income with New Discoveries Aug 24 2015
Aquinox’s Journey from the Bottom to the Top Aug 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK